Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 312  

    Article Cited by others

ORIGINAL ARTICLE

177Lu-DOTATATE peptide receptor radionuclide therapy in metastatic or advanced and inoperable primary neuroendocrine tumors of rare sites

Thapa Pradeep, Parghane Rahul, Basu Sandip

Year : 2017| Volume: 16| Issue : 3 | Page no: 223-228

   This article has been cited by
 
1 The battle on time, money and precision: Da[18F] id vs. [68Ga]liath
Sabri Sahnoun,Patrick Conen,Felix M. Mottaghy
European Journal of Nuclear Medicine and Molecular Imaging. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 A rare rarity: Neuroendocrine tumor of the esophagus
Elisa Giannetta,Valentina Guarnotta,Francesca Rota,Federica de Cicco,Federica Grillo,Annamaria Colao,Antongiulio Faggiano
Critical Reviews in Oncology/Hematology. 2019; 137: 92
[Pubmed]  [Google Scholar] [DOI]

 

Read this article